Non-canonical NFκB activation promotes chemokine expression in podocytes

IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin - ScienceDirect

Overview of the canonical and non-canonical NF-κB signaling pathways.

Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF‑κB pathway

Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?, Arthritis Research & Therapy

IJMS, Free Full-Text

Frontiers Cellular phenotypic transitions in diabetic nephropathy: An update

Frontiers Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis

PDF) Non-canonical NFκB activation promotes chemokine expression in podocytes

Neutralization of tumor necrosis factor receptor 2 (TNFR2) on podocytes

TWEAK, a multifunctional cytokine in kidney injury - ScienceDirect